Topical preparations for the treatment of psoriasis: Results of a retrospective study over 15 years

Journal of Dermatological Treatment

Volumn 19, Issue 3, 2008, Pages 134-140

  Zampetti, Anna ^a,c   Barone, Alessia ^a   Antuzzi, Daniela ^a   Amerio, Paolo ^b   Tulli, Antonello ^b   Feliciani, Claudio ^a   Amerio, Pierluigi ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b UNIVERSITY OF CHIETI   (Italy)

^c FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

Author keywords

Calcipotriene; Clobetasol; Eosin; Psoriasis

Indexed keywords

ANTIINFECTIVE AGENT; CADE OIL; CALCIPOTRIOL; CLOBETASOL PROPIONATE; EOSIN; PETROLATUM;

ADOLESCENT; ADULT; AGED; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PSORIASIS; RETROSPECTIVE STUDY; TOPICAL TREATMENT; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADMINISTRATION, CUTANEOUS; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS; CALCITRIOL; CLOBETASOL; DERMATOLOGIC AGENTS; DRUG THERAPY, COMBINATION; EOSINE YELLOWISH-(YS); FEMALE; HUMANS; MALE; MIDDLE AGED; PLANT EXTRACTS; PSORIASIS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SKIN; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME;

EID: 45849090366     PISSN: 09546634     EISSN: 14711753     Source Type: Journal    
DOI: 10.1080/09546630701846087     Document Type: Article

References (24)

1. Naldi L. Epidemiology of psoriasis. Curr Drug Targets Inflamm Allergy. 2004;3:121-8.
2. Krueger G, Ellis GN. Psoriasis - recent advances in understanding its pathogenesis and treatment. J Am Acad Dermatol. 2005;53:S94-100.
3. Naldi L, Griffiths CE. Traditional therapies in the management of moderate to severe chronic plaque psoriasis: An assessment of the benefits and risks. Br J Dermatol. 2005;152:597-615.
4. Lebwohl M, Ting PT, Koo JY. Psoriasis treatment: Traditional therapy. Ann Rheum Dis. 2005;64(S2), 83-6.
5. Norris DA. Mechanisms of action of topical therapies and the rationale for combination therapy. J Am Acad Dermatol. 2005;53:S17-25.
6. Aaa A. Final report on the safety assessment of Juniperus communis Extract, Juniperus oxycedrus Extract, Juniperus oxycedrus Tar, Juniperus phoenicea extract, and Juniperus virginiana Extract. Int J Toxicol. 2001;20 suppl 2: 41-56.
7. Von Tappeiner V, Jesonek A. Use of eosin and light for skin diseases. Munch Med Wochenschr. 1903;50:2042.
8. Kipnis VM. Treatment of psoriasis with ultraviolet radiation in combination with 1% alcohol solution of eosin. Vestn Dermatol Venerol. 1978;3:70-2.
9. Leigheb G, Gallus D, Spano G. Treatment of psoriasis with an antiseptic combination in to double-blind comparison versus eosin. G Ital Dermatol Venereol. 2000;135/1:107.
10. Bessier L. Eosin baths and some elements in the treatment of dermo-epidermitis and leg ulcers. Bull Soc Fr Dermatol Syphiligr. 1963;70:882-3.
11. Shohat M, Mimouni M, Varsano I. Efficacy of topical application of glucocorticosteroids compared with eosin in infants with seborrheic dermatitis. Cutis. 1987;40:67-8.
12. Monafo WW, Freedman BB. Topical therapy for burns. Surg Clin North Am. 1987;67:133-45.
13. Guilhou JJ. Calcipotriol. Ann Dermatol Venereol. 2001;128:229-37.
14. Del Rosso J, Friedlander SF. Corticosteroids: Options in the era of steroid-sparing therapy. J Am Acad Dermatol. 2005;53:S50-8.
15. Cockayne SE, Cork MJ, Gawkrodger DJ. Treatment of psoriasis: Day care vs. inpatient therapy. Br J Dermatol. 1999;140:375-6.
16. Prodanovich S, Kirsner RS, Taylor JR. Treatment of patients hospitalized for psoriasis. Dermatol Clin. 2000;18:425-35.
17. Schmitt J, Heese E, Wozel G, Meurer M. Effectiveness of inpatient treatment on quality of life and clinical disease severity in atopic dermatitis and psoriasis vulgaris - a prospective study. Dermatology. 2007;214:68-76.
18. Gerdes S, Mrowietz U. Classical topical therapy of psoriasis. Hautarzt. 2006;57:666-71.
19. Griffiths CE, Barker JN. Pathogenesis and clinical features of psoriasis. Lancet. 2007;370:263-71.
20. Feliciani C, Zampetti A, Amerio PL, Picardo M, Mastrofrancesco A, Flori E, et al. Effects on pro-inflammatory cytokines in HaCat cells treated by tetrabromofluorescin (Eosin). J Invest Dermatol. Abstr Book A. 2005;49:285.
21. Kragballe K, Barnes L, Hamberg KJ, Hutchinson P, Murphy F, Moller S, et al. Calcipotriol cream with or without concurrent topical corticosteroid in psoriasis: Tolerability and efficacy. Br J Dermatol. 1998;139:649-54.
22. Lahfa M, Mrowietz U, Koenig M, Simon JC. Calcitriol ointment and clobetasone propionate cream: A new regimen for the treatment of plaque psoriasis. Eur J Dermatol. 2003;13:261-5.
23. Van de Kerkhof PCM. Reduction of epidermal abnormalities and inflammatory changes in psoriatic plaques during treatment with vitamin D3 analogs. J Investig Dermatol Symp Proc. 1996;1:78-81.
24. Kang S, Yi S, Griffiths CEM, Fancher L, Hamilton TA, Choi JH. Calcipotriene-induced improvement in psoriasis is associated with reduced interleukin-8 and increased interleukin-10 levels within lesions. Br J Dermatol. 1998;138:77-83.